Da Fu

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Baiyong Shen · 4 shared papers, 2022–2025 · strength 0.69
   • Paper A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. DOI 10.1007/s13402-023-00818-5↗
   • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
   • Paper Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/B… DOI 10.1186/s13045-022-01348-7↗
2. Yu‐Shui Ma · 6 shared papers, 2014–2025 · strength 0.69
   • Paper The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. DOI 10.1016/j.jare.2024.01.014↗
   • Paper KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA net… DOI 10.1016/j.heliyon.2024.e24287↗
   • Paper microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3… DOI 10.1016/j.cellsig.2021.110025↗
3. Xiaomei Tang · 3 shared papers, 2023–2025 · strength 0.54
   • Paper The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. DOI 10.1016/j.jare.2024.01.014↗
   • Paper KLK10/LIPH/PARD6B/SLC52A3 are promising molecular biomarkers for the prognosis of pancreatic cancer through a ceRNA net… DOI 10.1016/j.heliyon.2024.e24287↗
   • Paper A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP1… DOI 10.1038/s41421-023-00592-6↗
4. Jiewei Lin · 3 shared papers, 2022–2023 · strength 0.51
   • Paper A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. DOI 10.1007/s13402-023-00818-5↗
   • Paper Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/B… DOI 10.1186/s13045-022-01348-7↗
   • Paper A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP1… DOI 10.1038/s41421-023-00592-6↗
5. Berina Šabanović · 3 shared papers, 2024–2025 · strength 0.50
   • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
   • Paper Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism. DOI 10.1002/advs.202308990↗
   • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
6. Quan Zheng · 3 shared papers, 2024–2025 · strength 0.50
   • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
   • Paper Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism. DOI 10.1002/advs.202308990↗
   • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
7. Chenlei Wen · 3 shared papers, 2024–2025 · strength 0.50
   • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
   • Paper Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism. DOI 10.1002/advs.202308990↗
   • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
8. Christopher Heeschen · 3 shared papers, 2024–2025 · strength 0.50
   • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
   • Paper Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism. DOI 10.1002/advs.202308990↗
   • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
9. Jingwei Li · 2 shared papers, 2023–2024 · strength 0.37
   • Paper A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. DOI 10.1007/s13402-023-00818-5↗
   • Paper Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism. DOI 10.1002/advs.202308990↗
10. Yizhi Cao · 2 shared papers, 2023–2025 · strength 0.36
    • Paper The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. DOI 10.1016/j.jare.2024.01.014↗
    • Paper A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP1… DOI 10.1038/s41421-023-00592-6↗
11. Jiajia Tang · 2 shared papers, 2024–2025 · strength 0.33
    • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
    • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
12. Elisabetta Fenocchio · 2 shared papers, 2024–2025 · strength 0.33
    • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
    • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
13. Yaru Zhao · 2 shared papers, 2024–2025 · strength 0.33
    • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
    • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
14. Qi Wang · 2 shared papers, 2024–2025 · strength 0.33
    • Paper Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells. DOI 10.1016/j.xpro.2025.103635↗
    • Paper CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches. DOI 10.1016/j.xcrm.2024.101692↗
15. Baiyong Shen · 2 shared papers, 2023–2024 · strength 0.32
    • Paper Gasdermin C promotes Stemness and Immune Evasion in Pancreatic Cancer via Pyroptosis-Independent Mechanism. DOI 10.1002/advs.202308990↗
    • Paper A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP1… DOI 10.1038/s41421-023-00592-6↗
16. Shuyu Zhai · 2 shared papers, 2022–2023 · strength 0.30
    • Paper Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/B… DOI 10.1186/s13045-022-01348-7↗
    • Paper A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP1… DOI 10.1038/s41421-023-00592-6↗
17. Xiaxing Deng · 2 shared papers, 2022–2023 · strength 0.30
    • Paper Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/B… DOI 10.1186/s13045-022-01348-7↗
    • Paper A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP1… DOI 10.1038/s41421-023-00592-6↗
18. Xiao‐Li Yang · 2 shared papers, 2021 · strength 0.22
    • Paper microRNA-873 inhibits self-renewal and proliferation of pancreatic cancer stem cells through pleckstrin-2-dependent PI3… DOI 10.1016/j.cellsig.2021.110025↗
    • Paper Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-… DOI 10.1186/s12967-021-03052-5↗
19. Xia Gao · 1 shared paper, 2025 · strength 0.22
    • Paper RBM10 inhibits pancreatic cancer development by suppressing immune escape through PD-1 expression. DOI 10.7150/jca.111459↗
20. Kun Tao · 1 shared paper, 2025 · strength 0.22
    • Paper RBM10 inhibits pancreatic cancer development by suppressing immune escape through PD-1 expression. DOI 10.7150/jca.111459↗
21. Hong Yu · 1 shared paper, 2025 · strength 0.21
    • Paper The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. DOI 10.1016/j.jare.2024.01.014↗
22. Yunfeng Wang · 1 shared paper, 2025 · strength 0.21
    • Paper The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. DOI 10.1016/j.jare.2024.01.014↗
23. Hong Jiang · 1 shared paper, 2025 · strength 0.21
    • Paper The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. DOI 10.1016/j.jare.2024.01.014↗
24. Haoyu Tang · 1 shared paper, 2025 · strength 0.21
    • Paper The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer. DOI 10.1016/j.jare.2024.01.014↗
25. Yuchen Ji · 1 shared paper, 2023 · strength 0.20
    • Paper A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis. DOI 10.1007/s13402-023-00818-5↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.